The numbers behind Nable NABL stock nobody talks about Grinds Lower 20260506 GOSS Gossamer Bio shares rise 521 percent even as Q4 2025 EPS narrowly misses analyst expectations How ChargePoint CHPT responds when competition intensifies 047 20260506 How Myriad Genetics MYGN manages its cash position Q1 2026 Earnings Fall Short